Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2008-01-01
2008-01-01
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S184100, C424S193100, C424S204100, C424S224100, C424S278100, C435S320100, C514S04400A, C536S023720
Reexamination Certificate
active
07314627
ABSTRACT:
The present invention relates to a method to introduce a nucleic acid molecule into a felid by administration of a nucleic acid-cationic lipid complex composition. The method includes the step of administering to the felid, by a parenteral route, a nucleic acid-cationic lipid complex to elicit and/or enhance an immune response. In one embodiment, this method enhances the immune response in a felid compared to a method in which a naked DNA vaccine is administered to a felid. Also provided is a method to deliver a nucleic acid to a felid. This method comprises parenterally administering to the felid a composition that includes a nucleic acid molecule complexed with a cationic lipid.
REFERENCES:
patent: 4726946 (1988-02-01), Bass et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 6120794 (2000-09-01), Liu et al.
patent: 6348196 (2002-02-01), Audonnet et al.
patent: WO 95/30019 (1995-11-01), None
patent: WO 98/03660 (1998-01-01), None
patent: WO 99/66879 (1999-12-01), None
Li et al., “A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice” Virology, vol. 356 Nos. 1-2, pp. 147-154 (Dec. 2006).
Patial et al., “Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2,” Vaccine, vol. 25. No. 20, pp. 4020-4028 (Epub Mar. 2007).
He et al., “Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent,” Journal of Virological Methods, vol. 356, pp. 147-151 (2006).
Koser et al., “Rabies virus nucleoprotein as a carrier for foreign antigens,” Proceedings of the National academy of Sciences, USA, vol. 101 No. 25, pp. 9405-9410 (Epub Jun. 2004).
Davis et al., 1997,Vaccine, vol. 15, No. 8, pp. 849-852.
Donnelly et al., 1997,Annu. Rev. Immunol., vol. 15, pp. 617-648.
Fynan et al., 1993,Proc. Natl. Acad. Sci. USA, vol. 90, pp. 11478-11482.
Gramzinski et al., 1998,Molecular Medicine, vol. 4, pp. 109-118.
Gregoriadis et al., 1997,FEBS Letters, vol. 402, pp. 107-110.
Ishii et al., 1997,Aids Research and Human Retroviruses, vol. 13, No. 16, pp. 1421-1428.
McCluskie et al., 1998,Antisense&Nucleic Acid Drug Development, vol. 8, pp. 401-414.
Norman et al., 1997,Vaccine, vol. 15, No. 8, pp. 801-803.
Osorio et al., 1999,Vaccine, vol. 17, pp. 1109-1116.
Philip et al., 1994,Molecular and Cellular Biology, pp. 2411-2418.
Stamatatos et al., 1988,Biochemistry, vol. 27, pp. 3917-3925.
Stopeck et al., 1998,Cancer Gene Therapy, vol. 5, No. 2, pp. 119-126.
Xiang et al., 1996,Virology, vol. 219, pp. 220-227.
Yokoyama et al., 1996,FEMS Immunology and Medical Microbiology, vol. 14, pp. 221-230.
Cuisinier, et al., 1997,Vaccine, vol. 15, No. 10, pp. 1085-1094.
Danko, et al., 1997,Human Molecular Genetics, vol. 6, No. 9, pp. 1435-1443.
Donnelly, et al., 1997,Vaccine, vol. 15, No. 8, pp. 865-868, Abstract.
Gramzinski, et al., 1998,Mol. Med., vol. 4, No. 2, pp. 109-118.
Hosie, et al., 1998,Journal of Virology, vol. 72, No. 9, pp. 7310-7319.
Mitchell, et al., 1995,Immunotechnology, vol. 1, No. 3-4, pp. 211-219.
Montgomery, et al., 1993,DNA Cell Biol., vol. 19, No. 9, pp. 777-783.
Ray, et al., 1997,Vaccine, vol. 15, No. 8, pp. 892-895.
Richardson, et al., 1997,Journal of Virology, vol. 71, No. 12, pp. 9640-9649.
Wheeler, et al., 1996,Proc. Natl. Acad. Sci., vol. 93, pp. 11454-11459.
Haynes Joel R.
Stinchcomb Dan T.
Wonderling Ramani S.
Heska Corporation
Lucas Zachariah
LandOfFree
Cationic lipid-mediated enhancement of nucleic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cationic lipid-mediated enhancement of nucleic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cationic lipid-mediated enhancement of nucleic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2786556